General—We maintain several equity incentive plans under which we may grant incentive stock options, nonqualified stock options, stock bonuses, restricted stock awards, restricted stock units and stock appreciation rights to employees (including officers), non-employee directors and consultants.

Stock-Based Compensation—Total stock-based compensation expense is recognized on our consolidated income statements as follows (in thousands):

	Fiscal Year Ended
	February 1, 2020		February 2, 2019		February 3, 2018
Cost of goods sold	$	1,265	$	1,130	$	1,001
Selling, general and administrative expenses		5,117		4,741		4,031
Total stock-based compensation expense	$	6,382	$	5,871	$	5,032

At February 1, 2020, there was $8.10 million of total unrecognized compensation cost related to unvested stock options and restricted stock. This cost has a weighted-average recognition period of 1.2 years.

Restricted Equity Awards —The following table summarizes the activity of restricted stock awards and restricted stock units, collectively defined as “restricted equity awards” (in thousands, except grant date weighted-average fair value):

	Restricted Equity Awards			Grant Date Weighted- Average Fair Value		Intrinsic Value
Outstanding at January 28, 2017		442		$	23.05
Granted		290		$	17.20
Vested		(183	)	$	22.67
Forfeited		(25	)	$	19.56
Outstanding at February 3, 2018		524		$	20.11
Granted		262		$	23.94
Vested		(217	)	$	20.85
Forfeited		(25	)	$	20.70
Outstanding at February 2, 2019		544		$	21.63
Granted		245		$	24.82
Vested		(218	)	$	22.17
Forfeited		(30	)	$	22.30
Outstanding at February 1, 2020		541		$	22.82	$	16,876

The following table summarizes additional information related to restricted equity awards activity (in thousands):

Stock Options—We had 0.3 million stock options outstanding at February 1, 2020 with a grant date weighted average exercise price of $23.38. We had 0.3 million stock options outstanding at February 2, 2019 with a grant date weighted average exercise price of $23.06 and 0.3 million stock options outstanding at February 3, 2018 with a grant date weighted average exercise price of $22.82.

Employee Stock Purchase Plan—We offer an Employee Stock Purchase Plan (“ESPP”) for eligible employees to purchase our common stock at a 15% discount of the lesser of fair market value of the stock on the first business day or the last business day of the offering period, subject to maximum contribution thresholds. The number of shares issued under our ESPP was less than 0.1 million for each of the fiscal years ended February 1, 2020, February 2, 2019 and February 3, 2018.